Hip and knee arthroplasties are increasingly common procedures with 62,196 procedures performed in Canada (excluding Quebec) from 2006 to 2007. This total is a 101% increase over the prior decade and a 6% increase over the prior year.[@CR1] Spinal anesthesia is a common choice of anesthesia for these procedures,[1](#Fn1){ref-type="fn"} which are often performed on elderly patients with comorbid conditions.

The risk for urinary retention after hip or knee arthroplasty has varied widely amongst different reports depending on the anesthesia and analgesia with estimates ranging from 0 to 75%.[@CR2] In one recent review, the authors estimated the pooled weighted mean incidence to be as low as 8.8% (95% confidence interval \[CI\] 5.2 to 12.4) for continuous peripheral nerve blockade to as high as 34.1% (95% CI 32.9 to 35.4) for epidural analgesia.[@CR2] Postoperative urinary retention can lead to significant morbidity, such as prosthetic infection and sepsis.[@CR2] Urinary retention following spinal anesthesia for hip or knee arthroplasty is well documented, but estimates of risks are based on small samples and vary widely amongst reports.[@CR2] Similarly, identification of risk factors for urinary retention in this population has resulted in discrepant conclusions.[@CR2]

The opening of the Centre for Surgical Innovation (CSI), an initiative to reduce wait times for hip and knee arthroplasties in the province of British Columbia (BC), Canada, provided us the opportunity to study a large homogeneous group of patients who underwent hip or knee arthroplasties under similar anesthetics. The purposes of this study were to estimate the 24-hr risk of postoperative urinary retention in a cohort of patients undergoing primary elective unilateral total hip or total knee arthroplasty and to identify risk factors for postoperative urinary retention in the same cohort.

Methods {#Sec1}
=======

This article on our single-centre cohort study is reported in accordance with the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) guidelines.[@CR3],[@CR4]

Study setting and participants {#Sec2}
------------------------------

In February 2006, the BC provincial government and the Vancouver Coastal Health Authority established the University of BC Hospital (Vancouver Acute) Centre for Surgical Innovation (CSI) and implemented the Osteoarthritis Service Integration System (OASIS) Program to reduce the wait times for elective major joint reconstructive surgery. The University of BC Hospital is a tertiary-referral centre in Vancouver, BC affiliated with the University of BC. The CSI focuses on elective primary total hip and knee replacement procedures. Patients requiring joint replacement from acute trauma, such as hip fractures, are ineligible. Participating orthopedic surgeons from all over the province identify and schedule eligible patients for surgery at the Centre. To avoid delays and cancellations, all CSI patients are evaluated at the Vancouver Acute anesthesia consult clinic at least 24 hr prior to surgery. The first hip and knee replacement procedures were performed on April 1, 2006.

Although the anesthetics were not standardized, they were similar amongst the members of the department. For general anesthesia, induction was achieved with intravenous fentanyl, propofol, and rocuronium. Anesthesia was maintained using sevoflurane or desflurane with rocuronium and long-acting intravenous opioids (morphine or hydromorphone) administered as needed. In some cases, an intravenous propofol infusion was added. For spinal anesthesia, neuraxial blockade was achieved using intrathecal long-acting local anesthetic (bupivacaine or ropivacaine) with intrathecal morphine added at the discretion of the attending anesthesiologist. All patients received cefazolin 2 g *iv* (or clindamycin 600 mg *iv* if penicillin allergy was documented) prior to surgical incision. Intravenous fluid therapy consisted of crystalloids (normal saline or Plasmalyte) only. All patients received oral oxycodone and patient-controlled analgesia with intravenous morphine or hydromorphone in the postoperative period. Physiotherapy and nursing care followed a clinical pathway to promote consistency of care. With regard to voiding, the nursing policy was to avoid routine intraoperative or postoperative catheterization of the patient's bladder due to concerns of infection.

As this was a retrospective study using patient records, the UBC Clinical Research Ethics Board waived the requirement for informed consent when it granted approval. After approval for access of information from the Vancouver Coastal Health Authority, hospital records of patients who were admitted to the CSI for primary hip or knee unilateral replacement procedures from April 1, 2006 to May 31, 2007 were identified through the Operating Room Management Information System (ORMIS) using the Vancouver Coastal Health procedure codes for primary hip and knee replacement procedures. Patients were included in this study if they met the Centre's admission criteria: age 14 to 80 yr, American Society of Anesthesiologists' (ASA) physical status class I-III, body mass index \<40 kg·m^−2^, pre-assessment 24-hr opiate consumption ≤60 mg oral morphine, consent given to receive blood transfusions, and absence of coagulation disorders or obstructive sleep apnea-hypopnea (based on overnight oximetry or polysomnography). Patients were excluded from this study if they had a history of chronic urinary retention (e.g., neurogenic bladder); they were admitted to the CSI but did not receive an anesthetic and undergo surgery (i.e., cancellation of case), or they received an indwelling bladder catheter intraoperatively. For patients who underwent more than one operation (on separate admissions) at the CSI, we used the data from the first admission only.

As we did not have a prior estimate of the rate of urinary retention in the population of interest at our Centre, our initial plan was to sample all eligible patients. After abstracting data from the records of 100 patients, we determined that all eligible patients were not necessary to achieve an adequate sample size (see below), and a random sample was chosen to save time and money. The order in which the paper records were sampled was randomized by the Health Record staff who held the master list of all eligible patients.

We abstracted data from individual patient paper records and entered our data directly into a Microsoft Excel™ spreadsheet. The spreadsheet included a data dictionary defining each variable and a guide to the source document where the variable could be located in the hospital record. To ensure consistency, each data abstractor (J.N., D.D., J.J.) underwent a training period wherein they and the senior investigator (P.T.C.) abstracted data independently from at least ten health records. When each data abstractor achieved 100% agreement with the senior investigator, s/he proceeded to abstract data independently. In addition, we conducted weekly internal consistency checks of the data tables to flag potential discrepancies or errors (e.g., coding "yes" for intrathecal morphine and coding "0 μg" for its dose) during the data collection period.

Variables {#Sec3}
---------

We abstracted data on variables related to demographics, comorbid conditions, preoperative medications, surgical and anesthetic details, surgical and anesthetic staff, times, and postoperative complications (including nausea, vomiting, pruritis, urinary retention in the first 24 hr after surgery, and postoperative pain during hospital admission). Values for variables derived from other variables (e.g., body mass index, durations) were calculated using formulae in the spreadsheet. Opioid dosages were recorded as equivalents in milligrams of morphine for each route of administration.

Study outcome {#Sec4}
-------------

The outcome for this analysis was urinary retention in the first 24 hr after surgery. The diagnostic criterion for urinary retention was postoperative urinary (intermittent or indwelling) catheterization due to 1) documented symptoms related to an inability to void after surgery or 2) postoperative urinary retention identified by bladder ultrasonography.

Sample size {#Sec5}
-----------

Our initial goal was to collect data from all patients meeting our selection criteria in the population of interest. After data had been collected on the first 100 patients, the estimated 24-hr risk of urinary retention was 42% (95% CI 32.8 to 52.8). The estimated 24-hr risk of urinary retention was 60% (21/35; 95% CI 43.6 to 74.5) in men and 32% (21/65; 95% CI 22.2 to 44.4) in women. Since the purpose of this study was to determine risk factors for urinary retention, we designed our sample size in order to assure stability around point estimates in a multivariable model, even when examining for subgroup effects (e.g., sex). Assuming 30% risk of urinary retention in females, with twelve covariates to be used in the final multivariable model (including interaction covariates) and using ten covariates per outcome as recommended by Peduzzi *et al.*,[@CR5] approximately 400 female patients would be required. Allowing for incomplete outcome and predictor ascertainment, we estimated that 1,000 patients would be sufficient for the number of variables to be included in a multivariable analysis. The precision of the point estimate (based on the 95% CI half-width) would range from 2.8% (for an incidence of 30%) to 3.1% (for an incidence of 50%) with 1,000 patients.

Statistical analyses {#Sec6}
--------------------

We used Stata release 10 (StataCorp, TX, USA) to analyze our data. We described categorical data, normally distributed data, and non-normally distributed data using proportions (percent), mean (standard deviation \[SD\]), and median (interquartile range \[IQR\]), respectively. Bivariate analysis of categorical and continuous data was performed using Chi square and two-sample Student's *t* tests, respectively. For the dosage of intrathecal morphine, we collapsed the continuous data into four strata (none, ≤100 μg, 101 to 150 μg, and \>150 μg). Similarly, we collapsed the data on intrathecal long-acting local anesthetic dosage into four strata (none, ≤10 mg, 10.1 to 12.5 mg, and \>12.5 mg). Multivariable logistic regression was used to model the association between postoperative urinary retention and independent variables. Independent variables were chosen *a priori* based on their potential association with the outcome variable reported in prior studies. These variables were: procedure (total hip *vs* total knee arthroplasty), age (yr), male sex, dose of intrathecal long-acting local anesthetic (as an ordinal variable), and dose of intrathecal long-acting morphine. The dose of long-acting intrathecal morphine was inserted as an indicator variable with the referent category being general anesthesia and the indicators being: spinal anesthesia without morphine, ≤100 μg, 101 to 150 μg, and \>150 μg. Fractional polynomials were used to ensure the best functional form of the continuous variable "age". Finally, we assessed for effect measure modification of sex by dose of intrathecal morphine by introducing interaction terms into the final model. A complete-case analysis was performed. All tests were two-sided and we considered a *P* value \<0.05 level to be statistically significant.

Results {#Sec7}
=======

From April 1, 2006 to May 31, 2007, 1,440 patients underwent 1,515 total hip or total knee arthroplasties. During this period, 1,366 patients, 73 patients, and one patient underwent one, two, and three major lower limb arthroplasties, respectively. By the time all data abstractors were notified that the sample size (1,000 patients) had been reached, we had abstracted data relating to the first procedure performed on 1,031 (71.3%) randomly sampled subjects of the 1,440 patients. The flow diagram for this study is shown in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Flow diagram of subjects studied

The mean age of the 1,031 patients was 61.8 (10.8) yr; 477 (46.3%) were men. The preoperative patient characteristics by postoperative urinary status are described in Table [1](#Tab1){ref-type="table"}. Of the 1,031 patients, 605 (58.7%) underwent total hip arthroplasties and 426 (41.3%) underwent total knee arthroplasties. Procedures were performed under spinal anesthesia (*n* = 844, 81.8%), general anesthesia (*n* = 105, 10.2%), or combined spinal and general anesthesia (*n* = 82, 8.0%). Patients spent 100 (IQR \[90-114\]) min in the operating room, 128 \[96-165\] min in the recovery room, and three \[3-4\] days in hospital. The operative and anesthetic characteristics by postoperative urinary status are described in Table [2](#Tab2){ref-type="table"}.Table 1Preoperative patient characteristics by status of postoperative urinary retentionUrinary retention (*n* = 446)No urinary retention (*n* = 585)*P* valueAge (yr), mean (SD)61.3 (10.5)62.2 (10.7)0.20Male sex, *n* (%)288 (64.6)189 (32.3)\<0.001Body mass index (kg·m^−2^), mean (SD)28.8 (5.4)29.3 (5.3)0.14ASA classification, *n* (%)0.04 I84 (18.8)78 (13.3) II347 (77.8)479 (81.9) III15 (3.4)28 (4.8)Smoking status, *n* (%)0.90 Non-smoker325 (72.9)434 (74.2) Ex-smoker85 (19.1)99 (16.9) Current smoker36 (8.1)52 (8.9)Preoperative opioid use, *n* (%)45 (10.1)70 (12.0)0.90Preoperative beta blocker use, *n* (%)28 (6.3)53 (9.1)0.10ASA = American Society of Anesthesiologists; SD = standard deviation Table 2Operative and anesthetic characteristics by status of postoperative urinary retentionUrinary retention (*n* = 446)No urinary retention (*n* = 585)*P* valueProcedure, *n* (%)\<0.001 Total knee arthroplasty157 (35.2)269 (46.0) Total hip arthroplasty289 (64.8)316 (54.0)Oral opioid postoperatively, *n* (%)87 (19.5)104 (17.8)0.40Type of anesthesia, *n* (%)\<0.001 General anesthesia23 (5.2)82 (14.2) General and spinal anesthesia41 (9.2)40 (6.8) Spinal anesthesia382 (85.7)462 (79.0) Missing01 (0.2)Intrathecal local anesthesia\* dose, *n* (%)\<0.001 General anesthesia only23 (5.2)82 (14.2) ≤10 mg94 (21.1)161 (27.5) 10.1--12.5 mg190 (42.6)224 (38.3) \>12.5 mg128 (28.7)105 (18.0) Missing11 (2.5)13 (2.2)Intrathecal morphine dose, *n* (%)\<0.001 General anesthesia only23 (5.2)82 (14.0) Spinal anesthesia without morphine42 (9.4)109 (18.6) ≤100 μg253 (56.7)287 (49.1) 101--150 μg89 (20.0)65 (11.1) \>150 μg37 (8.3)34 (5.8) Missing2 (0.5)8 (1.4)Median minutes in operating room \[IQR\]101 \[90--115\]100 \[90--113\]0.26Median minutes in recovery room \[IQR\]130 \[98--165\]125 \[95--165\]0.48Median days of hospital stay \[IQR\]3 \[3--4\]3 \[3--4\]0.62\* Bupivacaine or ropivacaine; IQR *=* interquartile range

The overall 24-hr risk of postoperative urinary retention was 43.3% (446/1031; 95% CI 40.3 to 46.3). The risk was 60.4% (288/477; 95% CI 55.9 to 64.7) amongst men and 28.5% (158/554; 95% CI 24.9 to 32.4) amongst women. On bivariate analysis, statistically significant differences (all *P* \< 0.001 unless noted) were observed for male sex, ASA physical status (*P* = 0.04), type of procedure, type of anesthetic, dose of intrathecal local anesthetic, and dose of intrathecal morphine (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). The final unadjusted and adjusted multivariable logistic regression models are presented in Table [3](#Tab3){ref-type="table"}. The final multivariable model included 435 outcome events in 1,006 patients. Both male sex and total hip arthroplasty (compared with total knee arthroplasty) were associated with increased odds of postoperative urinary retention. Compared with general anesthesia alone, any intrathecal morphine administration was associated with increased odds of postoperative urinary retention. We did not identify a dose-response relationship when we examined only those patients who received any intrathecal morphine (test-for-trend *P* = 0.07).Table 3Multivariable logistic regression analysis of factors that are related to postoperative urinary retentionVariableOR~unadj~OR~adj~95% CI*P* valueTotal hip arthroplasty1.61.41.1 to 1.90.02Age (yr)0.991.01.0 to 1.00.85Dose of intrathecal long-acting local anesthetic1.51.20.94 to 1.40.17Type of anesthetic by gender Male  General anesthesia only1.01.0-  Spinal anesthesia without intrathecal morphine1.51.60.71 to 3.60.26  ≤100 μg intrathecal morphine6.57.13.6 to 14.0\<0.001  101--150 μg8.69.34.2 to 20.1\<0.001  \>150 μg11.612.24.3 to 34.5\<0.001 Female  General anesthesia only1.01.0-  Spinal anesthesia without intrathecal morphine1.31.30.59 to 2.90.51  ≤100 μg intrathecal morphine1.71.70.84 to 3.30.14  101--150 μg2.82.61.2 to 5.80.02  \>150 μg1.51.40.53 to 3.60.51CI = confidence interval; OR~adj~ = adjusted odds ratio; OR~unadj~ = unadjusted odds ratio

As stated in the previous section, there was effect measure modification on dose of intrathecal morphine by sex (interaction *P* \< 0.001). These results are presented in Fig. [2](#Fig2){ref-type="fig"}. For males, there was a strong relationship between presence of intrathecal morphine and the odds of postoperative urinary retention that was not present for females. Compared with general anesthesia alone, males receiving spinal anesthesia with morphine had a 7.1 to 12.2-fold increased odds of postoperative urinary retention. Once again, we did not see a dose-response relationship (test-for-trend *P* = 0.13). For both males and females, spinal anesthesia without morphine was not associated with postoperative urinary retention.Fig. 2Odds ratios of urinary retention by dose of intrathecal morphine and gender

Discussion {#Sec8}
==========

In this single tertiary centre cohort study, the 24-hr risk of postoperative urinary retention after elective primary unilateral total hip or total knee arthroplasty was 43.3% (95% CI 40.3 to 46.3). Male sex, total hip arthroplasty, and the presence of any dose of intrathecal morphine were associated with this complication. Furthermore, the increased risk of postoperative urinary retention with intrathecal morphine appeared to be confined primarily to males, as evident from significant effect measure modification in our cohort.

Our results are consistent with the results from many prior studies. However, as with all observational studies, unmeasured and residual confounding are potential sources of bias in this study. The fast-track nature of the OASIS Program meant that patients at the CSI were relatively young healthy subjects with few comorbid conditions compared with subjects in prior studies.[@CR6]--[@CR10] As a result, there may be some selection bias and an underestimate of the risk of urinary retention.

The nurses were unblinded to the anesthetic agents in this study, and there was a potential bias that nurses were more likely to insert a bladder catheter in patients receiving intrathecal morphine, which could overestimate the effect of intrathecal morphine on the risk of urinary retention. However, formal clinical pathways were used during the study period, and the nursing policy was to avoid routine bladder catheterization.

Several studies have found age \>70 yr to be a risk factor for postoperative urinary retention.[@CR8],[@CR11] We did not identify age as a risk factor in our cohort. Our Centre's upper age limit of 80 yr may explain why age was not associated with urinary retention in our study sample. Furthermore, any inference of age must be interpreted with caution as the interquartile range was 55-70 yr.

Prior studies have identified obstructive urological symptoms to be associated with postoperative urinary retention following major lower joint arthroplasty.[@CR2] Although we excluded patients with a history of chronic urinary retention, we did not exclude patients with benign prostatic hypertrophy. Unlike prospective studies evaluating preoperative urinary tract or prostate symptoms,[@CR7],[@CR8],[@CR12] we could not determine a history of obstructive urological symptoms with accuracy due to our reliance on existing records; thus, we did not examine preoperative urological symptoms as a variable in our study. Compared with women, the increased risk of postoperative urinary retention amongst men receiving intrathecal morphine may be related to prostate symptoms.

Similarly, perioperative fluid administration may play a role in the development of postoperative urinary retention by overdistension of the bladder.[@CR2] As we were unable to abstract accurate data from the patients' medical records regarding the volume of fluids administered, we did not examine the perioperative fluid administration as a variable in our study.

In a very recent cohort study, Hansen *et al.* found lack of preoperative voiding to be associated with postoperative urinary retention (OR 4.20; 95% CI 2.46 to 7.16).[@CR13] Unfortunately, we did not collect this information in our study, and we can neither corroborate nor refute this association.

In spite of potential biases, our study has several strengths. The anesthetic, surgical, and nursing practices at the CSI were very uniform to maximize efficiency and patient flow from hospital admission to hospital discharge. The high volume of the two surgical procedures allowed us to achieve a large sample size in this study.

Our results are generalizable to orthopedic centres that have large volumes of reasonably healthy patients undergoing major lower limb joint arthroplasty. The results may be applicable to older sicker patients undergoing the same procedure but are likely to be an underestimate of the true risk.

Since dissemination of our results within our own centre, we have implemented bladder ultrasonography in the recovery room for earlier diagnosis of this common complication. Even though urinary retention is associated with an increased risk of urinary tract infections and subsequent prosthetic infection, the use of prophylactic indwelling bladder catheters is still debatable as indwelling catheters also increase the risk of urinary tract infections.[@CR2] Voiding immediately prior to surgery, early diagnosis of urinary retention, and intermittent catheterization may be the best approach.[@CR2],[@CR13]--[@CR16] Based on our results, individuals who are undergoing total hip arthroplasty or are male will be at an increased risk. For men, this risk is increased in the presence of intrathecal morphine.

Available at <http://www.postoppain.org/content.aspx?nid=57632> and <http://www.postoppain.org/image.aspx?imgid=654> (Both accessed 24 March 2010).
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